CEP-701

lestaurtinib · Cephalon

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for CEP-701, covering 2011-05-04 to 2012-08-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of CEP-701 in Treatment of Prostate Cancer [Phase 2]